Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy CommunicationsNOW IN
    Article

    Therapeutic Effect and Possible Herb Drug Interactions of Ginger (Zingiber officinale Roscoe, Zingiberaceae) Crude Extract with Glibenclamide and Insulin

    Ihsan L. Al-Omari1★, Fatma U. Afifi2, Abdulazim S. Salhab1★ Corresponding author

    1. 1Department of Pharmacology, Faculty of Medicine, University of Jordan, Amman, JORDAN.
    2. 2Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, JORDAN.

    CORRESPONDENCE

    Ihsan L. Al-Omari

    Department of Pharmacology, Faculty of Medicine, University of Jordan, Amman, JORDAN.

    eh_omari@yahoo.com

    Volume 2, Issue 1 · pp. 12–20 · PUBLISHED · DOI: 10.5530/pc.2012.1.4

    View on Pharmacogn. Commn. original site ↗

    ABSTRACT

    Background:Zingiber officinale aqueous extracts have traditionally been used by diabetic patients in Jordan. Objective:The present study aims to evaluate the hypoglycemic and antihyperglycemic effects of ginger crude extract (GCE) in normoglycemic- and streptozotocin (STZ)- diabetic- rats and to assess the possible herb-drug interactions with glibenclamide and insulin. Materials and Methods: Oral glucose tolerance test (OGTT) was determined for GCE at concentrations 25, 50 and 100 mg/kg body weight (BW). GCE was administered to normoglycemic rats as a single dose (1 day) and as a daily dose for 1 week. STZ diabetic rats were treated with the same GCE concentrations (25, 50 and 100 mg/kg BW) together with glibenclamide (5 mg/kg BW) or insulin (1.2 IU/kg BW). Results:Single administration of GCE showed a significant decrease in blood glucose level (BGL) in normoglycemic rats at 1 and 2 h (50 mg/kg BW; p<0.001) while one week administration of GCE did not improve BGL. In STZ- diabetic rats GCE (25 and 50 mg/kg BW) decreased non-fasting BGL (N-FBGL) significantly (p<0.001) at 1.5, 2.5, 3.5 and 4.5 h. The combinations of Glibenclamide (5 mg/kg BW) and GCE at doses (25 or 50 mg/kg BW) exhibited after 4.5 h a significantly reduction in the N-FBGL 26.3% (p<0.001) and 25.1% (p<0.01) respectively; while glibenclamide alone exhibited 7.9% reduction. Also co-administration of GCE (50 mg/kg BW) with insulin caused a significant reduction in the N-FBGL at 2.5 (p<0.001) and 3.5 h (p<0.01) compared to insulin alone. Conclusions:The observed interaction of ginger with glibenclamide and insulin appears to be promising in reducing blood glucose levels and needs further evaluation.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Al-Omari, I. L., Afifi, F. U., & Salhab, A. S. (). Therapeutic Effect and Possible Herb Drug Interactions of Ginger (Zingiber officinale Roscoe, Zingiberaceae) Crude Extract with Glibenclamide and Insulin. Pharmacognosy Communications, 2(1), 12–20. https://doi.org/10.5530/pc.2012.1.4